The key challenge for us at this Summit—as laid out implicitly
by the electorates, patients, and stakeholders we represent—is to grapple in practical
terms with how we best integrate these opportunities into our healthcare systems. We cannot stand on the sidelines...
Healthcare needs to move from being our greatest
modern cost to becoming our greatest modern asset.
William Castell, Chairman, Wellcome Trust
A multi-year dialogue as ambitious as the Pacific Health Summit could not be successful without the support of forward-thinking organizations, foundations, and individuals. Our sponsors and supporting organizations play a vital role in creating this historic opportunity—to bridge borders, traverse new policies, stem disease, and save lives—full partners on an expedition to scale the heights of disease detection and prevention. The Summit is grateful for their financial support and partnership.
Sponsors | Supporting Organizations| Founding Organization | Presenting Organizations
Founded in 1975, Microsoft is the worldwide leader in software, services, and solutions that help people and businesses realize their full potential. Microsoft's global vision enables its diverse workforce to generate innovative ideas and develop new technology. Through these ideas, Microsoft has developed the deep foundation necessary to support the communities that we work and live in each day.
demonstrated its leadership by becoming the first organization to sponsor the Pacific Health Summit and has continued to support the Summit each year. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE) employing more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. GE Healthcare is an integral part of GE’s “healthymagination” vision to help customers to deliver better care to more people around the world at a lower cost. In addition, the program will improve the health and competitiveness of GE’s employees and encourages GE Healthcare to partner with healthcare leaders and governments striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. For more information on healthymagination, please click here.
The Coca-Cola company is the largest nonalcoholic beverage company in the world. Along with
Coca-Cola, the Company markets four of the world's top-five soft drinks, including diet Coke, Fanta, and Sprite, and nearly 400 brands and more than 2,100 products worldwide including low- and no-calorie soft drinks, juices and juice drinks, waters, sports and energy drinks, teas, coffees, soy based drinks, and fortified beverages with nutritional benefits. In 2004, the Company established the Beverage Institute for Health & Wellness to advance understanding of role that beverages, and beverage ingredients, can play in nutrition, health, and wellness.
Sanofi-aventis is a diversified global healthcare company, focused on patient needs. Core strengths are a worldwide presence, market leadership in vaccines, and major biological products. In addition to prescription pharmaceuticals and vaccines, company business activities include consumer healthcare products, generics, and animal health products. With almost 100,000 employees in more than 100 countries, sanofi-aventis posted sales of more than 27.5 billion Euros in 2008, including 22.9 billion Euros in pharmaceutical business and 2.8 billion Euros in the human vaccines business, where Sanofi Pasteur is a world leader. As a healthcare leader, sanofi-aventis is concerned about global public health issues: to meet the needs of countries in the Southern hemisphere, we work through 'Access to medicines' programs to combat malaria, tuberculosis, sleeping sickness, leishmaniasis, and epilepsy.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than 1.6 billion doses of vaccines in 2008, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than 1 million Euros in research and development.
GlaxoSmithKline (GSK) is one of the world’s leading research-based pharmaceutical and healthcare companies committed to improving the quality of human life by enabling people to do more, feel better, and live longer. GSK is one of the few pharmaceutical companies researching both medicines and vaccines for WHO's three priority diseases - HIV/AIDS, tuberculosis, and malaria and is proud to have developed some of the leading global medicines in these fields. Headquartered in the UK with offices in over 100 countries and major research centers in the UK, USA, Belgium, and China, GSK represents an estimated five percent of the world's pharmaceutical market. But being a leader brings responsibility. GSK believes that it must help developing countries where debilitating disease affects millions of people and access to life-changing medicines and vaccines is a problem. To meet this challenge, GSK is committed to providing discounted medicines where they are needed the most. GSK also produces medicines that treat major disease areas such as asthma, virus control, infections, mental health, diabetes, and digestive conditions. In addition, GSK is a leader in the area of vaccines and is developing new treatments for cancer.
Merck & Co., Inc. is a global health research company dedicated to improving humanity through treatment identification, prevention and cures of unmapped diseases. As one of the largest pharmaceutical facilities in the world, Merck discovers and produces medicines and vaccines in over 20 remedial categories. Merck is committed to putting patients first and dedicates resources towards reaching remote locations to provide the most advanced health essentials for those in need.
Johnson & Johnson is a comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. Our long-standing operating model has four simple concepts: being broadly based in human health; managing our business for the long term; taking a decentralized management approach; and focusing on our people and values. Our Family of Companies comprises a premier consumer health care company, the world’s largest and most diverse medical devices and diagnostics company, and a broad pharmaceuticals segment. Our approach to innovation has resulted in a robust portfolio of diverse pharmaceutical products that address public healthcare needs, including access and affordability, in meaningful ways.
PepsiCo is one of the world’s largest food and beverage companies. Its principal businesses include: Frito-Lay snacks, Pepsi-Cola beverages, Gatorade sports drinks, Tropicana juices, and Quaker foods. PepsiCo’s commitment to sustainable growth, defined as Performance with Purpose, is focused on generating healthy financial returns while giving back to communities the Company serves. This includes meeting consumer needs for a spectrum of convenient foods and beverages, reducing the Company’s impact on the environment through water, energy, and packaging initiatives, and supporting its employees through a diverse and inclusive culture. In 2007 we made great progress toward human sustainability by reformulating some of our existing products to improve their nutritional profile, launching new products that reflect consumer demand for healthier, nutritious snacks and beverages, partnering with governments, health officials, and nongovernmental organizations to help address obesity concerns and continuing to grow our portfolio of smart spot eligible products.
Chevron is one of the world's leading integrated energy companies, with subsidiaries that conduct business worldwide. Chevron is the largest resource holder and producer among international oil companies in Asia-Pacific. The company's success is driven by the ingenuity and commitment of approximately 62,000 employees who operate across the energy spectrum. Chevron explores for, produces, and transports crude oil and natural gas; refines, markets, and distributes transportation fuels and other energy products; manufactures and sells petrochemical products; generates power and produces geothermal energy; provides energy efficiency solutions; and develops the energy resources of the future, including biofuels and other renewables. Chevron is based in San Ramon, California.
ZGF is an internationally recognized architecture, planning, and interior design firm with over 450 personnel and offices in Seattle, Portland, New York, Los Angeles, and Washington, D.C. The firm has received over 300 design awards, including the Architecture Firm Award, the highest accolade given to a firm by the American Institute of Architects. As a leading designer of a broad range of facilities, including healthcare and medical research, ZGF is passionate about creating buildings that provide the best possible healing environments for patients and their families, achieve operational efficiencies enabling the highest level of medical care, and inspire cutting-edge medical research and discoveries. This includes projects across the United States and internationally (Europe, Africa, South America, Asia, Middle East). Clients include Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering, The Johns Hopkins University, Stanford University, U.S. National Institutes of Health, U.S. Food & Drug Administration, University of California, and Duke University, among others. Recent work internationally includes the Beijing FuWai Hospital of Cardiovascular Disease and Beijing Children’s Hospital Leukemia Center in China, and Weill Cornell Medical College Vivarium in Doha, Qatar.
Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka—people creating new products for better health worldwide.” Otsuka is committed to being a corporation that creates global value, adhering to the high ethical standards, maintaining a dynamic corporate culture, and working in harmony with local communities and the natural environment. The Otsuka Pharmaceutical Group comprises 106 companies and employs approximately 33,000 people in 18 countries and regions worldwide. Osuka was recognized by Treatment Action Group as the fourth largest funder of tuberculosis research globally and the largest industry funder. The Novel Products Opportunities Division within Otsuka Pharmaceutical Development and Commercialization, a US based subsidiary, is leading the development of a new compound for the treatment of tuberculosis, OPC-67683, and conducting an ongoing Phase II Study at 12 sites in 7 countries.
Swedish Medical Center
is the largest, most comprehensive, nonprofit health-care provider in Seattle. Swedish is comprised of four hospital campuses (First Hill, Cherry Hill, Ballard and Edmonds), a new community-based emergency room and specialty center in Issaquah, Redmond and Mill Creek, Swedish Home Care Services and Swedish Physicians' a network of 12 primary-care clinics. In addition to general medical and surgical care, Swedish is known as a regional referral center, providing specialized treatment in areas such as cardiac care, oncology, orthopedics, high-risk obstetrics, neurological care, sleep medicine, pediatrics, organ transplantation, and clinical research. Swedish has also taken a leadership role in providing community health delivery innovations, including a Medical Home on its Ballard campus and a community specialty clinic at First Hill.
Miraca Holdings Inc., headquartered in Tokyo, provides a wide variety of diagnostic products and over 4,000 clinical testing services through its affiliated companies, including Fujirebio Inc., Fujirebio Diagnostics Inc. (Pennsylvania, U.S., formerly Centocor Diagnostics), and SRL, Inc. With its primary focus on developing, manufacturing, and marketing of in vitro diagnostics, medical devices and testing services, Miraca Holdings is and will be committed to global healthcare.
The University of Washington Department of Global Health is one of the first of its kind, established jointly in the School of Medicine and the School of Public Health with a mandate to harness the extraordinary expertise, energy, and creativity of faculty across all UW schools and colleges to create one of the most comprehensive academic global health programs in the world. The department is home to six centers with more than 1,000 staff members worldwide. The department also has more than 140 faculty with projects in more than 70 countries and continues to grow.
We Work for Health educates policymakers, opinion leaders, and the media about the economic impact of the life sciences innovation pipeline in Washington, and seeks to raise awareness of the impact of public policy on innovation in the life sciences, related industries, and surrounding communities.
The Stop TB Partnership—established by the World Health Assembly in May 2000, following a call from the Ministerial Conference on Tuberculosis & Sustainable Development in Amsterdam two months earlier—is a network of more than 1000 countries, donors, national and international organizations, government and nongovernmental organizations, academics, and individuals working together to reduce the toll of TB worldwide and ultimately achieve a world free of TB. The Partnership consists of a Partners’ Forum; a Coordinating Board; a Partnership Secretariat, hosted by the World Health Organization (WHO) in Geneva, Switzerland; and seven working groups. Our vision is a TB-free world.
RESULTS Educational Fund, and its affiliate offices, is committed to educating the public, media, and leaders about issues related to domestic and global poverty and hunger. REF holds public forums, trains citizens in democracy, holds media conference calls to share the latest information, and produces quality oversight research to determine the effectiveness of programs for the poor.
The Rockefeller Foundation envisions a world with Smart Globalization – a world in which globalization’s benefits are more widely shared and social, economic, health, and environmental challenges are more easily weathered. We support work that enables individuals, communities, and institutions to access new tools, practices, resources, services, and products. The Foundation today supports work that enhances their resilience in the face of acute crises and chronic stresses, whether manmade, ecological, or both. This is the 21st century interpretation of the Foundation’s pioneering – and enduring – philanthropic mission to “promote the well-being” of humanity. Significant advances toward Smart Globalization are still undermined by insufficient food, water, and shelter; inadequate health systems; worsening environmental degradation and climate change; unplanned urbanization; and declining social and economic security. These dangers interact with and intensify each other. They cannot be effectively resolved in isolation.
Eli Lilly and Company makes medicines that help people live longer, healthier, and more active lives. The Lilly MDR-TB Partnership was created to confront multi-drug resistant tuberculosis. Since 2003, the public-private initiative, mobilizing 18 partners on five continents, has worked together in the quest to contain and conquer one of the world's oldest diseases. Through programs that include technology transfer, community-based training, surveillance, and research and development, Lilly and its partners share expertise on behalf of MDR-TB patients in 60 countries.
The National Cancer Institute (NCI) is a component of the National Institutes of Health, a division of the U.S. Department of Health and Human Services. NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
Becton Dickinson is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems, and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria is a coalition of more than 220 companies united to keep the fight against these epidemics a global priority. The Coalition provides tailored support so that companies can take an active role in defeating the pandemics. The Coalition also organizes collective actions among companies and links the public and private sectors in ways that pool talents and resources. The official focal point of the private sector delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Coalition maintains offices in New York, Paris, Johannesburg, Beijing, Nairobi, and Moscow.
The Washington Global Health Alliance (WGHA) works to enhance and expand Washington’s global health impact and showcase the region’s role as a leading center for global health activities. Executive Partners include the Fred Hutchinson Cancer Research Center, Global Alliance for the Prevention of Prematurity and Stillbirth-an initiative of Seattle Children's, Infectious Disease Research Institute, Institute for Systems Biology, Pacific Northwest National Laboratory, PATH, Public Health-Seattle & King County, Seattle Biomedical Research Institute, University of Washington Department of Global Health, Washington State University School for Global Animal Health, and the Bill & Melinda Gates Foundation.
Virginia Mason is a private, not-for-profit organization that includes a teaching hospital licensed for 336 beds in Seattle and a network of primary and specialty care clinics in western Washington. The organization’s vision is to be the Quality Leader in health care. Virginia Mason’s concept of quality is all-encompassing. It includes hiring the finest physicians and staff, achieving the best clinical outcomes, and providing unsurpassed service for patients and their families. Virginia Mason is at the forefront of medical treatment and research with programs such as The Heart Institute, Floyd & Delores Jones Cancer Institute, Center for Hyperbaric Medicine, Bailey-Boushay House, and Benaroya Research Institute.
The Washington Biotechnology & Biomedical Association (WBBA) is a nonprofit membership association for life sciences and related companies and research institutions in the state of Washington. Based in Seattle, WBBA has more than 430 member companies and seven staff. WBBA is governed by a volunteer board of directors and offers its members social and educational events, a purchasing consortium, online resources, a member newsletter and advocacy in the state capitol of Olympia. A statewide strategy for the life sciences is being implemented by WBBA members, while working together to provide better health for people everywhere.
The Russell Family Foundation was created as a way for the extended Russell family to make a quiet, positive impact in the community. Founded with part of the proceeds from the sale of the Frank Russell Company to Northwestern Mutual Life in 1999, The Russell Family Foundation seeks to demonstrate integrity, mutual trust, constructive communication, life-long learning and courage in all of its activities.
The National Bureau of Asian Research (NBR) is a nonprofit, nonpartisan institution that conducts advanced research on policy-relevant issues in Asia. It also serves as the global clearinghouse for Asian research conducted by specialists and institutions worldwide. Through these activities NBR is uniquely positioned to promote informed and effective U.S. policy toward the region.
The Fred Hutchinson Cancer Research Center is an independent, nonprofit research institution dedicated to the development of lifesaving therapies through biomedical research. The center is recognized for its pioneering and leading-edge research that is focused on eliminating cancer and many other devastating diseases.
Guided by the belief that every life has equal value, The Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we focus on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, we seek to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, the Foundation is led by CEO Jeff Raikes and Co-Chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust’s breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests.